GuidePrimary care
Screening for oesophageal adenocarcinoma in chronic GERD (CTFPHC 2020)
Canadian recommendation on screening endoscopy for adenocarcinoma, Barrett oesophagus or dysplasia in adults with chronic reflux.
Updated 3 November 2026
When to use it
In an adult with chronic GERD without alarm features, when deciding whether to order gastroscopy solely to rule out Barrett oesophagus or cancer.
Warning
The CTFPHC ended its mandate on 31 March 2026: its guidelines remain published but are no longer updated (the Public Health Agency of Canada now supports a national advisory committee). They are Canadian recommendations: check them against your national or regional screening programme.
Who it applies to
Adults (≥ 18 years) with chronic gastro-oesophageal reflux disease. It concerns screening for oesophageal adenocarcinoma and its precursor lesions (Barrett oesophagus, dysplasia).
Keep reading in the app
- Recommendation
- Alarm features (not screening: investigate)
- Rationale
Practical tip
It strongly recommends against screening (very low certainty), even with risk factors such as age ≥ 50, male sex, abdominal obesity or smoking.
2 more practical tips in the app.
Reference
Official source: CTFPHC guideline (Canadian Task Force on Preventive Health Care)
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
